Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

BACKGROUND: Neuroimaging measures and chemical biomarkers may be important indices of clinical progression in normal aging and mild cognitive impairment (MCI) and need to be evaluated longitudinally. OBJECTIVE: To characterize cross-sectionally and longitudinally clinical measures in normal controls...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Petersen, R C., Aisen, P S., Beckett, L A., Donohue, M C., Gamst, A C., Harvey, D J., Jack, C R., Jagust, W J., Shaw, L M., Toga, A W., Trojanowski, J Q., Weiner, M W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Academy of Neurology 2010
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809036/
https://ncbi.nlm.nih.gov/pubmed/20042704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181cb3e25
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados